Frequency Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
48
- Latest Deal Type
-
M&A
Frequency Therapeutics General Information
Description
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
Contact Information
Website
www.frequencytx.comCorporate Office
- 75 Hayden Avenue
- Suite 300
- Lexington, MA 02421
- United States
Corporate Office
- 75 Hayden Avenue
- Suite 300
- Lexington, MA 02421
- United States
Frequency Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 03-Nov-2023 | Completed | Generating Revenue | |||
| 8. PIPE | 20-Jul-2020 | Completed | Generating Revenue | |||
| 7. IPO | 03-Oct-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 18-Jul-2019 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 31-Dec-2018 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC (Series B) | 31-Oct-2018 | Completed | Clinical Trials - Phase 2 | |||
| 3. Grant | 30-May-2018 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 05-Jan-2018 | $32M | $43M | Completed | Startup | |
| 1. Early Stage VC | $11M | $11M | Completed | Startup |
Frequency Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A1 | 10,000 | $0.001000 | 8% | $0.75 | $0.75 | 1x | $0.75 | 0% |
| Series A | 64,891,735 | $0.001000 | 8% | $0.75 | $0.75 | 1x | $0.75 | 30.68% |
Frequency Therapeutics Comparisons
Industry
Financing
Details
Frequency Therapeutics Competitors (31)
One of Frequency Therapeutics’s 31 competitors is Decibel Therapeutics, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Decibel Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Neurona Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Oligomerix | Venture Capital-Backed | White Plains, NY | ||||
| VeriNOS Pharmaceuticals | Private Equity-Backed | Wuerzburg, Germany |
Frequency Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Frequency Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Frequency Therapeutics Former Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Axil Capital Partners | Venture Capital | Minority | ||
| Cobro Ventures | Venture Capital | Minority | ||
| DF Investments One | Lender/Debt Provider | Minority | ||
| Deerfield Management | Venture Capital | Minority |
Frequency Therapeutics Acquisitions (1)
Frequency Therapeutics’s most recent deal was a Reverse Merger with Korro Bio. The deal was made on 03-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Korro Bio | 03-Nov-2023 | Reverse Merger | Drug Discovery |
Frequency Therapeutics ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
33.72 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,638
Rank
Percentile
Pharmaceuticals
Industry
of 1,008
Rank
Percentile
Biotechnology
Subindustry
of 465
Rank
Percentile
Frequency Therapeutics FAQs
-
When was Frequency Therapeutics founded?
Frequency Therapeutics was founded in 2015.
-
Where is Frequency Therapeutics headquartered?
Frequency Therapeutics is headquartered in Lexington, MA.
-
What is the size of Frequency Therapeutics?
Frequency Therapeutics has 48 total employees.
-
What industry is Frequency Therapeutics in?
Frequency Therapeutics’s primary industry is Drug Discovery.
-
Is Frequency Therapeutics a private or public company?
Frequency Therapeutics is a Private company.
-
What is Frequency Therapeutics’s current revenue?
The current revenue for Frequency Therapeutics is .
-
How much funding has Frequency Therapeutics raised over time?
Frequency Therapeutics has raised $273M.
-
Who are Frequency Therapeutics’s investors?
Alexandria Venture Investments, Axil Capital Partners, Cobro Ventures, DF Investments One, and Deerfield Management are 5 of 20 investors who have invested in Frequency Therapeutics.
-
Who are Frequency Therapeutics’s competitors?
Decibel Therapeutics, Neurona Therapeutics, NexImmune, Oligomerix, and VeriNOS Pharmaceuticals are some of the 31 competitors of Frequency Therapeutics.
-
When was Frequency Therapeutics acquired?
Frequency Therapeutics was acquired on 03-Nov-2023.
-
Who acquired Frequency Therapeutics?
Frequency Therapeutics was acquired by Korro Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
